Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Immunoglobulin G - China Biologic Products

Drug Profile

Immunoglobulin G - China Biologic Products

Alternative Names: Human immunoglobulin; Human immunoglobulin 10%; Human immunoglobulin 5%; Immunoglobulin intravenous 10% - China Biologic Products; Immunoglobulin intravenous 5% - China Biologic Products; Intravenous immunoglobulin - China Biologic Products; IVIG - China Biologic Products

Latest Information Update: 28 Nov 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator China Biologic Products
  • Class Immunoglobulin isotypes
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Immunodeficiency disorders

Most Recent Events

  • 25 Feb 2016 China Biologic Products receives approval for clinical trial by the CFDA (China Biologic Products, Form 10-K, February 2016)
  • 01 Jan 2014 Launched prior to 2014 for Immunodeficiency disorders in China (IV; 5% and 10%)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top